Literature DB >> 3206004

Cross-over trials, carry-over effects and the art of self-delusion.

S J Senn1.   

Abstract

Mesh：

Year:  1988        PMID： 3206004     DOI： 10.1002/sim.4780071010

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  7 in total

1.  Problems with the two stage analysis of crossover trials.

Authors:  S J Senn
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

2.  Should we cross off the crossover?

Authors:  P Armitage
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

3.  A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.

Authors:  Chii-Dean Lin; Kung-Jong Lui
Journal:  Pharm Stat       Date:  2021-11-09       Impact factor: 1.234

Review 4.  Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis.

Authors:  Tobias N Bonten; Chiara E I Plaizier; Jaap-Jan D Snoep; Theo Stijnen; Olaf M Dekkers; Johanna G van der Bom
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

Review 5.  Basic design considerations for clinical trials in oncology.

Authors:  S Piantadosi; N Saijo; T Tamura
Journal:  Jpn J Cancer Res       Date:  1992-06

Review 6.  Design, analysis, and presentation of crossover trials.

Authors:  Edward J Mills; An-Wen Chan; Ping Wu; Andy Vail; Gordon H Guyatt; Douglas G Altman
Journal:  Trials       Date:  2009-04-30       Impact factor: 2.279

7.  Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.

Authors:  Pierre Kalfon; Olivier Mimoz; Anderson Loundou; Marie-Agnès Geantot; Nathalie Revel; Isabelle Villard; Julien Amour; Elie Azoulay; Maïté Garrouste-Orgeas; Claude Martin; Tarek Sharshar; Karine Baumstarck; Pascal Auquier
Journal:  Trials       Date:  2016-02-16       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.